Intussusception (ileocolic / ileoileal) — pediatric
Encounter flow
12/12 authoredCanonical 12-phase frame with authored status for this dossier.
Frame
Frame the suspected pediatric intussusception presentation: age band (< 3 mo / 3-6 mo / 6 mo - 3 y / > 3 y / > 6 y) drives pretest probability + pathologic-lead-point consideration; 6 mo - 3 y is classic high-pretest cohort with highest enema-success rates; < 3 mo or > 6 y atypical → high lead-point suspicion. Duration of symptoms drives ischemia / perforation risk; > 24 h higher failure rate; > 48 h relative surgical indication.
Age band + duration tagged; pretest probability + lead-point suspicion framing set
Patient inputs (24)
Age band drives pretest probability + pathologic-lead-point consideration: < 3 mo or > 6 y atypical bands → high lead-point suspicion + surgical management preferred over enema; 6 mo - 3 y is classic-presentation band with highest enema-success rates
Weight-based dosing for all fluids + analgesia + sedation drugs; weight at presentation
Tachycardia + dehydration in prolonged duration; bradycardia + hypotension flags perforation/shock
Capillary refill > 3 s + mottling = dehydration / shock — pre-enema resuscitation required; severe dehydration is enema contraindication
Fever may suggest viral precipitant (URI ~ 30% precede) OR perforation with peritonitis; serial trend useful
Paroxysmal episodes drawing knees up = classic; constant pain may indicate ischemia / perforation
Sausage-shaped mass typically RUQ or epigastrium (Dance sign — empty RLQ); peritoneal signs (rigidity, guarding, rebound) → perforation; distention → progression
Viral URI precedes ~ 30% of cases; adenovirus most strongly associated (lymphoid hyperplasia of Peyer's patches → lead point); supports diagnosis in age-appropriate child
Transient post-vaccine intussusception risk window 1-21 d after dose 1 (~ 1 per 20-100K vaccinated); AAP statement continues to recommend vaccination — net benefit far exceeds risk; document for surveillance + family counseling
HSP-associated intussusception is typically ileoileal — surgical management more often than enema; document for rheumatology consult + management pivot
Recurrence ~ 10%; recurrent (≥ 2 episodes) raises pathologic lead-point suspicion (Meckel's, polyp, lymphoma) — evaluate via colonoscopy / Meckel's scan / contrast study after acute recovery
Currant-jelly stool (mucus + blood) is late finding (~ 60% of cases); occult blood on rectal exam more common early; normal stool does not rule out intussusception
Leukocytosis with left shift may suggest ischemia / perforation; baseline + serial
Electrolyte derangements from vomiting + dehydration; AKI from prolonged dehydration; baseline pre-sedation
First-line diagnostic — target sign on transverse / pseudokidney sign on longitudinal; sensitivity > 97%, specificity ~ 100% (ACR Appropriateness Criteria; Applegate 2005); bedside-accessible; no ionizing radiation
Plain KUB is non-diagnostic for intussusception itself but rules out free air pre-enema attempt; consider lateral decubitus view
Hypotension by age-appropriate threshold → surgical emergency contraindicates enema (perforation / shock concern)
Episodic lethargy ~ 10% atypical presentation; persistent lethargy raises concern for shock / sepsis
Duration > 24 h correlates with higher rates of bowel ischemia + enema failure + perforation; > 48 h is relative surgical indication
Pre-surgical type-and-screen if surgical management likely (failed enema, perforation, shock)
CF, prior abdominal surgery, intestinal duplication, polyposis syndromes (Peutz-Jeghers) raise pretest probability + lead-point likelihood
Reserved for post-recovery lead-point evaluation (Meckel's scan, MR enterography) in recurrent or atypical-age-band cases — NOT acute workup
Elevated lactate suggests bowel ischemia → relative surgical indication even pre-enema; > 4 mmol/L is concerning
Pneumatic (air) enema preferred over hydrostatic (Daneman 2003 retrospective; Sadigh AJR 2015 meta-analysis); BOTH diagnostic confirmation AND first-line therapy; reduction success ~ 80-90% in age-appropriate uncomplicated cases; complication rate ~ 1% perforation
* = hard-required. Engine cannot meaningfully run until these are filled.
Severity triggers (9)
- informationallife_threateningintussusception_with_perforation_or_shockIntussusception with perforation (free air on KUB, peritonitis on exam) OR hemodynamic compromise (hypotension by age threshold, tachycardia with poor perfusion, capillary refill > 3 s, mottling) OR shock (lactate ≥ 4, vasoactive medication required) — life-threatening surgical emergency; enema is CONTRAINDICATED; emergent operating room + ICU + IV fluid resuscitation + broad-spectrum antibiotics (ACR Appropriateness Criteria; SSC peds 2020 for shock physiology)Trigger could not be auto-evaluated — needs clinician judgement.
- informationallife_threateningenema_complication_perforationEnema complication — perforation during pneumatic or hydrostatic enema (air or contrast extravasation on fluoroscopy, sudden hemodynamic decompensation, sudden abdominal distention) — life-threatening; immediately stop enema, decompress with needle aspiration if tension pneumoperitoneum, emergent OR + ICU + broad-spectrum antibiotics + vasoactive if shock; perforation rate ~ 1% per attempt with appropriate technique (ACR Appropriateness Criteria; Daneman 2003)Trigger could not be auto-evaluated — needs clinician judgement.
- informationalsevereintussusception_age_under_3mo_or_over_6yIntussusception in atypical age band — < 3 months OR > 6 years — high index of suspicion for pathologic lead point (Meckel's diverticulum, intestinal polyp, lymphoma, duplication cyst, vascular malformation); surgical management preferred over enema in these cohorts; consider lead-point workup pre- or post-reduction depending on stability (ACR Appropriateness Criteria; Daneman 2003)Trigger could not be auto-evaluated — needs clinician judgement.
- informationalseverefailed_enema_reduction_at_3_attemptsFailed pneumatic enema reduction at 3 maximum attempts (capped at 120 mmHg air pressure per ACR Appropriateness Criteria) — operating room for surgical reduction (laparoscopic preferred; open if unstable or large pathologic lead point); do NOT attempt > 3 enemas (Daneman 2003)Trigger could not be auto-evaluated — needs clinician judgement.
- informationalsevereintussusception_after_24h_duration_higher_failure_rateIntussusception with symptom duration > 24 h — higher rates of bowel ischemia + enema-reduction failure + perforation; duration > 48 h is relative surgical indication (ACR Appropriateness Criteria; pediatric surgery literature)Trigger could not be auto-evaluated — needs clinician judgement.
- informationalseverehsp_associated_intussusceptionHenoch-Schönlein purpura (HSP)-associated intussusception — typically ileoileal type (vs more common ileocolic in non-HSP); enema-reduction success substantially lower; surgical management more often than enema; rheumatology consult for ongoing HSP management (pediatric rheumatology literature)Trigger could not be auto-evaluated — needs clinician judgement.
- informationalsevererecurrent_intussusception_evaluate_lead_pointRecurrent intussusception (≥ 2 episodes, ~ 10% recurrence rate usually within 24-48 h of initial reduction) — evaluate for pathologic lead point: Meckel's diverticulum (Tc-99m pertechnetate scan), intestinal polyp (colonoscopy / contrast study), lymphoma (cross-sectional imaging + biopsy), duplication cyst, vascular malformation; especially high suspicion in age < 3 mo or > 6 y; pediatric GI + pediatric surgery coordinationTrigger could not be auto-evaluated — needs clinician judgement.
- informationalseverepediatric_dehydration_pre_enema_resuscitationPediatric dehydration pre-enema — severe dehydration is an enema contraindication; IV fluids REQUIRED before any enema attempt; resuscitation per AAP DDC / Gorelick scoring; bolus 20 mL/kg NS over 30-60 min, repeat × 1-2 PRN; reassess for fluid overload after each bolus (halt or slow if hepatomegaly, rales, no response) (AAP pediatric resuscitation principles; ACR Appropriateness Criteria)Trigger could not be auto-evaluated — needs clinician judgement.
- informationalmildobservation_24h_post_enema_recurrence_watchPost-successful enema 24-hour inpatient observation for recurrence-watch — ~ 10% recurrence usually within 24-48 h post-reduction; serial abdominal exams q2-4h; diet advance from clear liquids → full liquids → soft → regular as tolerated; family bedside instruction on return precautions (return of paroxysmal pain, vomiting, bloody stool → notify nurse) (ACR Appropriateness Criteria; AAP)Trigger could not be auto-evaluated — needs clinician judgement.
Workflow calculators
Run this disease's risk and dosing calculators inline.
Recommended regimen
Pre-enema resuscitation + sedation + analgesia for pediatric intussusception (ACR Appropriateness Criteria + AAP pediatric sedation guidance)- normal saline / lactated Ringer'sfirst linecrystalloid_isotonic20 mL/kg IV bolus over 30-60 min, repeat × 1-2 PRN; max ~ 60 mL/kg total before reassessing for fluid overload • IV • bolus PRN with reassessmenttriggers: intussusception_diagnosis_with_dehydration, pre_enema_resuscitation_required, pediatric_dehydration_pre_enemaACR Appropriateness Criteria — pre-enema resuscitation REQUIRED if severe dehydration; lower bolus thresholds vs adult sepsis given pediatric fluid-overload risk; halt or slow if hepatomegaly / rales / no response (AAP pediatric resuscitation principles)rxcui 9863
- morphinefirst lineopioid_analgesic0.05-0.1 mg/kg IV every 2-4 h PRN; titrate to comfort • IV • q2-4h PRNtriggers: intussusception_pain_management_pre_or_post_enemaAnalgesia for paroxysmal pain; titrate to comfort without obscuring abdominal examrxcui 7052
- ketaminefirst linedissociative_anesthetic1-2 mg/kg IV by pediatric sedation team for procedural sedation; supplemental 0.5 mg/kg PRN • IV • proceduraltriggers: intussusception_enema_procedural_sedation_pediatricPreferred procedural-sedation agent for air-enema (preserves airway reflexes + analgesic); per institutional pediatric sedation protocol + AAP pediatric sedation guidancerxcui 6130
- dexmedetomidineadd onalpha2_agonist_sedative1 mcg/kg IV load over 10 min then 0.2-0.7 mcg/kg/h continuous; alternative procedural sedation option • IV • load then continuoustriggers: ketamine_contraindicated_or_alternative_sedation_preferredAlternative procedural-sedation; useful when ketamine contraindicated (psychotic features, increased ICP concerns); per institutional protocolrxcui 48937
- midazolamadd onbenzodiazepine0.05-0.1 mg/kg IV (max 2 mg single dose) for anxiolysis adjunct • IV • PRN proceduraltriggers: adjunct_anxiolysis_for_procedural_sedationAdjunct anxiolysis; not stand-alone procedural sedation in this contextrxcui 6960
- ceftriaxonecomorbidity specificthird_gen_cephalosporin50 mg/kg IV (max 2 g) single dose at induction; expand to broad-spectrum if perforation • IV • pre-op single dose; broader if perforationtriggers: perforation_or_surgical_management_requiredPre-op antimicrobial prophylaxis for surgical reduction; expand to pip-tazo or carbapenem + metronidazole if perforation / peritonitis confirmedrxcui 2193
- piperacillin-tazobactamrescuepenicillin_BLI80-100 mg/kg IV q6-8h (piperacillin component) for confirmed perforation / peritonitis • IV • q6-8htriggers: perforation_with_peritonitis_confirmedBroad Gram-positive + Gram-negative + anaerobe single-agent backbone for intra-abdominal contamination per Solomkin IDSA intra-abdominal 2010 (peds-adapted)rxcui 74169
- metronidazolerescuenitroimidazole10 mg/kg IV q8h (max 500 mg/dose); add to ceftriaxone for anaerobic cover when pip-tazo not available • IV • q8htriggers: perforation_anaerobic_cover_when_pip_tazo_unavailableAnaerobic cover adjunct; alternative to single-agent pip-tazorxcui 6922
outpatient playbook — drug actions (4)
- 1. PO analgesia as neededacetaminophen 10-15 mg/kg PO q4-6h PRN (max 75 mg/kg/day or 4 g/day adult-equivalent) • PO • PRNtrigger: Post-recovery mild discomfortStandard pediatric mild pain control
- 2. continue HSP-specific corticosteroids if rheumatologist-managedprednisolone 1-2 mg/kg/day PO (max 60 mg/day) — per rheumatology • PO • dailytrigger: HSP-associated case with rheumatology guidancePer pediatric rheumatology HSP-management protocol; not initiated by GI/surgical team
- 3. NO ongoing antibiotic prophylaxisN/A • N/A • N/Atrigger: Uncomplicated post-recoveryNo prophylactic antibiotics post-intussusception (ACR + AAP)
- 4. continue routine vaccines per ACIP including future rotavirus doses if applicableper ACIP age-based schedule • PO (rotavirus) or IM (others) • per ACIPtrigger: Routine well-child careAAP statement — net benefit of rotavirus vaccination far exceeds individual intussusception risk; continue vaccination schedule unless contraindicated
Auto-drafted A&P note
outpatientSubjective
- Possible entry pathways: Child 6 mo - 3 y with paroxysmal abdominal pain in episodes lasting 5-30 min separated by quiet intervals (drawing knees up; inconsolable crying); classic intussusception ENTRY signal (ACR Appropriateness Criteria; AAP NEC-adjacent surgical-emergency guidance); Currant-jelly stool (mucus + blood) or bloody stool in child 6 mo - 3 y — pathognomonic but late finding (~ 60% of cases); LR+ ~ 10 for intussusception in age-appropriate cohort; Palpable sausage-shaped abdominal mass typically RUQ or epigastrium (Dance sign — empty RLQ) — third element of classic triad; LR+ ~ 8.
Objective
- No vitals, labs, or imaging entered for this encounter.
Assessment
**Intussusception (ileocolic / ileoileal) — pediatric** (peds.intussusception.v1). Phenotype framing: Acute gastroenteritis (vomiting + diarrhea + dehydration but lacks paroxysmal pain pattern + currant-jelly stool); volvulus (especially midgut — bilious emesis in younger infant; upper-GI series); incarcerated inguinal hernia (palpable groin mass; surgical emergency in its own right); Meckel's diverticulum bleed (painless bleeding distinct from intussusception's painful presentation); appendicitis (older child > 5 y; RLQ pain; Alvarado / PAS score); HSP without intussusception (purpura + abdominal pain but no target sign on US); psychogenic abdominal pain (older child; lacks paroxysmal pattern + objective findings). Scope: Frame the suspected pediatric intussusception presentation: age band (< 3 mo / 3-6 mo / 6 mo - 3 y / > 3 y / > 6 y) drives pretest probability + pathologic-lead-point consideration; 6 mo - 3 y is classic high-pretest cohort with highest enema-success rates; < 3 mo or > 6 y atypical → high lead-point suspicion. Duration of symptoms drives ischemia / perforation risk; > 24 h higher failure rate; > 48 h relative surgical indication. No severity triggers fired against current inputs.
Plan
Regimen axis: **Pre-enema resuscitation + sedation + analgesia for pediatric intussusception (ACR Appropriateness Criteria + AAP pediatric sedation guidance)**. 1. normal saline / lactated Ringer's 20 mL/kg IV bolus over 30-60 min, repeat × 1-2 PRN; max ~ 60 mL/kg total before reassessing for fluid overload IV bolus PRN with reassessment (crystalloid_isotonic, first line) — ACR Appropriateness Criteria — pre-enema resuscitation REQUIRED if severe dehydration; lower bolus thresholds vs adult sepsis given pediatric fluid-overload risk; halt or slow if hepatomegaly / rales / no response (AAP pediatric resuscitation principles) 2. morphine 0.05-0.1 mg/kg IV every 2-4 h PRN; titrate to comfort IV q2-4h PRN (opioid_analgesic, first line) — Analgesia for paroxysmal pain; titrate to comfort without obscuring abdominal exam 3. ketamine 1-2 mg/kg IV by pediatric sedation team for procedural sedation; supplemental 0.5 mg/kg PRN IV procedural (dissociative_anesthetic, first line) — Preferred procedural-sedation agent for air-enema (preserves airway reflexes + analgesic); per institutional pediatric sedation protocol + AAP pediatric sedation guidance 4. dexmedetomidine 1 mcg/kg IV load over 10 min then 0.2-0.7 mcg/kg/h continuous; alternative procedural sedation option IV load then continuous (alpha2_agonist_sedative, add on) — Alternative procedural-sedation; useful when ketamine contraindicated (psychotic features, increased ICP concerns); per institutional protocol 5. midazolam 0.05-0.1 mg/kg IV (max 2 mg single dose) for anxiolysis adjunct IV PRN procedural (benzodiazepine, add on) — Adjunct anxiolysis; not stand-alone procedural sedation in this context 6. ceftriaxone 50 mg/kg IV (max 2 g) single dose at induction; expand to broad-spectrum if perforation IV pre-op single dose; broader if perforation (third_gen_cephalosporin, comorbidity specific) — Pre-op antimicrobial prophylaxis for surgical reduction; expand to pip-tazo or carbapenem + metronidazole if perforation / peritonitis confirmed 7. piperacillin-tazobactam 80-100 mg/kg IV q6-8h (piperacillin component) for confirmed perforation / peritonitis IV q6-8h (penicillin_BLI, rescue) — Broad Gram-positive + Gram-negative + anaerobe single-agent backbone for intra-abdominal contamination per Solomkin IDSA intra-abdominal 2010 (peds-adapted) 8. metronidazole 10 mg/kg IV q8h (max 500 mg/dose); add to ceftriaxone for anaerobic cover when pip-tazo not available IV q8h (nitroimidazole, rescue) — Anaerobic cover adjunct; alternative to single-agent pip-tazo Setting playbook (outpatient) — Post-discharge pediatrician + (if indicated) pediatric GI + pediatric surgery + rheumatology follow-up. Most intussusception cases recover completely with no long-term sequelae. Recurrent cases (≥ 2 episodes) require lead-point workup. HSP-associated cases require rheumatology follow-up. 9. PO analgesia as needed acetaminophen 10-15 mg/kg PO q4-6h PRN (max 75 mg/kg/day or 4 g/day adult-equivalent) PO PRN — Post-recovery mild discomfort (Standard pediatric mild pain control) 10. continue HSP-specific corticosteroids if rheumatologist-managed prednisolone 1-2 mg/kg/day PO (max 60 mg/day) — per rheumatology PO daily — HSP-associated case with rheumatology guidance (Per pediatric rheumatology HSP-management protocol; not initiated by GI/surgical team) 11. NO ongoing antibiotic prophylaxis N/A N/A N/A — Uncomplicated post-recovery (No prophylactic antibiotics post-intussusception (ACR + AAP)) 12. continue routine vaccines per ACIP including future rotavirus doses if applicable per ACIP age-based schedule PO (rotavirus) or IM (others) per ACIP — Routine well-child care (AAP statement — net benefit of rotavirus vaccination far exceeds individual intussusception risk; continue vaccination schedule unless contraindicated) Non-pharmacologic actions: - Family education reinforcement on return precautions - Pediatric GI lead-point workup if recurrent (≥ 2 episodes): contrast study (upper-GI / small-bowel follow-through) + Meckel's scan (Tc-99m pertechnetate; sensitivity ~ 85% if age > 2 y) + colonoscopy if age-appropriate; MR enterography for polyposis syndromes (Peutz-Jeghers; familial polyposis) - Pediatric surgery wound / scar / bowel function review post-op - Rheumatology HSP management if applicable - VAERS report if post-rotavirus-vaccine case (CDC surveillance) - Routine well-child care + ongoing vaccination per ACIP - Family caregiver psychosocial check at follow-up (acute illness in young child can be traumatic) AVOID / contraindication checks: - No enema attempt if perforation suspected or confirmed (free air on KUB, peritonitis on exam) (ACR Appropriateness Criteria) - No enema attempt if shock or severe dehydration unresponsive to resuscitation (ACR Appropriateness Criteria) - Do NOT attempt > 3 enema reductions (ACR Appropriateness Criteria + Daneman 2003) - Pneumatic enema cap pressure at 120 mmHg (ACR Appropriateness Criteria) - Hydrostatic enema cap at 1 m height of contrast column above patient (ACR) - Pediatric sedation team must be in attendance for ketamine/dexmedetomidine procedural sedation (AAP pediatric sedation guidance) - Pediatric surgery must be in attendance or immediately available during enema attempt (ACR Appropriateness Criteria; AAP) - Ceftriaxone avoid under 28 days bilirubin displacement (FDA 2009; AAP Puopolo 2018 — applies only if neonatal presentation < 28 d which is atypical for intussusception but possible) - Fluid bolus 20 mL per kg with reassessment pediatric AAP DDC (AAP pediatric resuscitation principles)
Monitoring
Regimen monitoring: - continuous vitals during enema procedure with pediatric sedation team - capnography during procedural sedation (AAP pediatric sedation guidance) - serial abdominal exam q15 min during enema attempts - post-enema vitals q1-2h × 6 h then q4h - fluid balance + UOP q1h × 6 h post-enema - pain re-assessment q2-4h with FLACC or age-appropriate scale - serial diet advance from clear liquids → full liquids → soft → regular as tolerated - family-bedside-instruction documentation on return precautions for recurrence signs Setting (outpatient) monitoring: - Pediatrician visit at 1-2 weeks, 4-6 weeks, then routine well-child care - Pediatric GI at 4-6 weeks if recurrent / atypical-age for lead-point workup - Pediatric surgery at 2-4 weeks post-op - Rheumatology per HSP schedule - Vaccination catch-up review at every well-child visit Follow-up plan: Pediatrician follow-up within 1-2 weeks; return precautions reviewed with caregivers (recurrence signs: return of paroxysmal pain episodes, vomiting, bloody stool, lethargy — present to ED). Recurrent intussusception (≥ 2 episodes) → pediatric GI consult for lead-point workup: contrast study (upper-GI / small-bowel follow-through) + Meckel's scan (Tc-99m pertechnetate) + considered colonoscopy if age-appropriate; MR enterography for polyposis syndromes (Peutz-Jeghers). HSP-associated cases → rheumatology follow-up for HSP management beyond acute event. Rotavirus vaccine surveillance: report post-vaccine cases to VAERS (CDC surveillance) per AAP recommendation; family counseling that net benefit far exceeds individual case risk. - Close-out criterion: Follow-up scheduled + return precautions delivered + lead-point workup queued if recurrent Monitoring phase: Post-enema: vitals q1-2h × first 6 h then q4h; serial abdominal exams q2-4h watching for recurrence (return of paroxysmal pain pattern) or post-procedure complication; advance diet from clear liquids → full liquids → soft → regular as tolerated; family at bedside + bedside instructions on recurrence signs (return of pain episodes, vomiting, bloody stool). Post-surgical: standard post-op care + early ambulation + diet advance per surgeon; ileus monitoring; wound infection surveillance.
Disposition
Current setting: outpatient — Post-discharge pediatrician + (if indicated) pediatric GI + pediatric surgery + rheumatology follow-up. Most intussusception cases recover completely with no long-term sequelae. Recurrent cases (≥ 2 episodes) require lead-point workup. HSP-associated cases require rheumatology follow-up. Disposition criteria: - Sustained recovery — normal diet + bowel function + growth at age-appropriate baseline + no recurrent episodes in 6-12 mo + lead-point workup negative if performed + family demonstrating return-precaution knowledge Escalation triggers (move to higher acuity): - New episode of paroxysmal pain + vomiting + bloody stool → return to ED for repeat US + management (recurrent intussusception) - Persistent post-op symptoms (pain, distention, abnormal bowel function) → urgent pediatric surgery + GI reassessment - New palpable purpura + abdominal pain in age-appropriate child → HSP-associated suspicion; rheumatology + ED reassessment - Family caregiver acute distress / PTSD symptoms after traumatic illness → mental-health referral
Earlier-Return Triggers
Return-precaution thresholds (watch for): - [LIFE_THREATENING] Intussusception with perforation (free air on KUB, peritonitis on exam) OR hemodynamic compromise (hypotension by age threshold, tachycardia with poor perfusion, capillary refill > 3 s, mottling) OR shock (lactate ≥ 4, vasoactive medication required) — life-threatening surgical emergency; enema is CONTRAINDICATED; emergent operating room + ICU + IV fluid resuscitation + broad-spectrum antibiotics (ACR Appropriateness Criteria; SSC peds 2020 for shock physiology) - [LIFE_THREATENING] Enema complication — perforation during pneumatic or hydrostatic enema (air or contrast extravasation on fluoroscopy, sudden hemodynamic decompensation, sudden abdominal distention) — life-threatening; immediately stop enema, decompress with needle aspiration if tension pneumoperitoneum, emergent OR + ICU + broad-spectrum antibiotics + vasoactive if shock; perforation rate ~ 1% per attempt with appropriate technique (ACR Appropriateness Criteria; Daneman 2003) - [SEVERE] Intussusception in atypical age band — < 3 months OR > 6 years — high index of suspicion for pathologic lead point (Meckel's diverticulum, intestinal polyp, lymphoma, duplication cyst, vascular malformation); surgical management preferred over enema in these cohorts; consider lead-point workup pre- or post-reduction depending on stability (ACR Appropriateness Criteria; Daneman 2003)
Citations
- ACR Appropriateness Criteria — Suspected Pediatric Intussusception + AAP statement on rotavirus vaccine + intussusception (post-licensure surveillance; net benefit favors continued vaccination) + Applegate KE AJR 2005 (imaging evidence-based review) + Daneman A Pediatr Radiol 2004 (pneumatic vs hydrostatic enema) + Sadigh G AJR 2015 (meta-analysis pneumatic vs hydrostatic) + Solomkin IDSA intra-abdominal 2010 (peds-adapted for perforation management) + SSC peds 2020 (for shock physiology if perforation precipitates sepsis) [PMID:16120899](https://pubmed.ncbi.nlm.nih.gov/16120899/) - Cited evidence (PMID 14634696) [PMID:14634696](https://pubmed.ncbi.nlm.nih.gov/14634696/) - Cited evidence (PMID 26496576) [PMID:26496576](https://pubmed.ncbi.nlm.nih.gov/26496576/) - Cited evidence (PMID 20034345) [PMID:20034345](https://pubmed.ncbi.nlm.nih.gov/20034345/) - Cited evidence (PMID 32191793) [PMID:32191793](https://pubmed.ncbi.nlm.nih.gov/32191793/) Last reconciled with current guidelines: 2026-05-25.
- ACR Appropriateness Criteria — Suspected Pediatric Intussusception + AAP statement on rotavirus vaccine + intussusception (post-licensure surveillance; net benefit favors continued vaccination) + Applegate KE AJR 2005 (imaging evidence-based review) + Daneman A Pediatr Radiol 2004 (pneumatic vs hydrostatic enema) + Sadigh G AJR 2015 (meta-analysis pneumatic vs hydrostatic) + Solomkin IDSA intra-abdominal 2010 (peds-adapted for perforation management) + SSC peds 2020 (for shock physiology if perforation precipitates sepsis) — PMID:16120899
- Cited evidence (PMID 14634696) — PMID:14634696
- Cited evidence (PMID 26496576) — PMID:26496576
- Cited evidence (PMID 20034345) — PMID:20034345
- Cited evidence (PMID 32191793) — PMID:32191793